Plasma membrane fluidity and polarity of polymorphonuclear leukocytes from children with type I diabetes mellitus

Journal of Diabetes and its Complications

Volumn 13, Issue 5-6, 1999, Pages 243-250

  Kantar, Ahmad ^a   Littarru, Gian Paolo ^a   Falcioni, Giancarlo ^b   Cherubini, Valentino ^a   Coppa, Giovanni Valentino ^a   Fiorini, Rosamaria ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 TRIMETHYLAMMONIUMPHENYL) 6 PHENYL 1,3,5 HEXATRIENE; FLUORESCENT DYE; HEMOGLOBIN A1C; HUMAN INSULIN; LAURDAN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEMBRANE FLUIDITY; MEMBRANE POTENTIAL; MEMBRANE STRUCTURE; NEUTROPHIL; PRIORITY JOURNAL;

ADOLESCENT; CELL MEMBRANE; CELL POLARITY; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; FLUORESCENCE POLARIZATION; HUMANS; MALE; MEMBRANE FLUIDITY; NEUTROPHILS; SPECTROMETRY, FLUORESCENCE;

EID: 0033549924     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(99)00051-3     Document Type: Article

References (49)

1. Delamaire M., Maugendre D., Moreno M., Le Goff M.C., Allannic H., Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med. 14:1997;29-34.
2. Wilson R.M. Neutrophil function in diabetes. Diabet Med. 3:1986;509-512.
3. Mowat A.G., Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med. 284:1971;621-627.
4. -) production and HbA1 level in diabetic patients. Diabetes Res Clin Pract. 21:1993;109-114.
5. Bagdade J.D., Walters E. Impaired granulocyte adherence in mildly diabetic patients. Diabetes. 29:1980;309-311.
6. Marhoffer W., Stein M., Maeser E., Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care. 15:1992;256-260.
7. Kantar A., Wilkins G., Swoboda B., Littarru G.P., Bertoli E., Catassi C., Coppa G., Giorgi P.L. Alterations of the respiratory burst of polymorphonuclear leukocytes from diabetic children. Acta Paediatr Scand. 79:1990;535-541.
8. Zozulinska D.A., Wierusz-Wysocka B., Wysocki H., Majchrzak A.E., Wykretowicz A. The influence of insulin-dependent diabetes mellitus (IDDM) duration on superoxide anion and hydrogen peroxide production by polymorphonuclear neutrophils. Diabetes Res Clin Pract. 33:1996;139-144.
9. Sawant J.M. Biochemical changes in polymorphonuclear leucocytes in diabetic patients. J Postgrad Med. 39:1993;183-186.
10. Watt A. Membrane structure and dynamics. Curr Opin Cell Biol. 1:1989;691-700.
11. Fiorini R., Curatola G., Bertoli E., Giorgi P.L., Kantar A. Changes of fluorescence anisotropy in plasma membrane of human polymorphonuclear leukocytes during the respiratory burst phenomenon. FEBS Lett. 273:1990;122-126.
12. Fiorini R., Valentino M., Gratton E., Bertoli E., Curatola G. Erythrocyte membrane heterogeneity studied using 1,6-diphenyl-1,3,5-hexatriene fluorescence lifetime distribution. Biochem Biophys Res Commun. 147:1987;460-466.
13. Fiorini R., Curatola G. Membrane heterogeneity studied by fluorescence lifetime distributions of DPH and TMA-DPH. Appl Fluorescence Technol. 3:1991;33-38.
14. Kantar A., Giorgi P.L., Curatola G., Fiorini R. Changes in plasma membrane microheterogeneity of polymorphonuclear leukocytes during the activation of the respiratory burst. Jesaitis A.J., Dratz E.A. Molecular Basis of Oxidative Damage by Leukocytes. 1992;243-246 CRC Press, Boca Raton, FL.
15. Fiorini R., Valentino M., Wang S., Glaser M., Gratton E. Fluorescence lifetime distribution of 1,6-diphenyl-1,3,5-hexatriene in phospholipid vesicles. Biochemistry. 26:1987;3864-3870.
16. Fiorini R., Curatola G., Kantar A., Giorgi P.L., Gratton E. Use of Laurdan fluorescence in studying plasma membrane organization of polymorphonuclear leukocytes during the respiratory burst. Photochem Photobiol. 57:1993;438-441.
17. Kantar A., Giorgi P.L., Fiorini R. Effect of PAF on polymorphonuclear leukocyte plasma membrane polarity. A fluorescence study Mediators of Inflamm. 2:1993;149-151.
18. Pozzi D., Lisi A., Lanzilli G., Grimaldi S. Role of membrane fluidity in Epstein Barr Virus (EBV) infectivity on Akata cell line. Biochim Biophys Acta. 1280:1996;161-168.
19. Dowhan W. Molecular basis for membrane phospholipid diversity. Why are there so many lipids? Annu Rev Biochem. 66:1997;199-232.
20. Kinnunen P.K.J., Koiv A., Lehtonen J.Y.A., Rytomaa M., Mustonen P. Lipid dynamics and peripheral interactions of proteins with membrane surface. Chem Phys Lipids. 73:1994;181-207.
21. Welti R., Glaser M. Lipid domains in model and biological membranes. Chem Phys Lipids. 73:1994;121-137.
22. Kinnunen P.K.J. On the principles of functional ordering in biological membranes. Chem Phys Lipids. 57:1991;375-399.
23. Lentz B.R. Membrane "fluidity" as detected by diphenylhexatriene probes. Chem Phys Lipids. 50:1989;171-190.
24. Van Ginkel G. Diphenylhexatrienes as fluorescent membrane probes. Appl Fluorescence Technol. 1:1989;1-8.
25. Illinger D., Duportail G., Mely Y., Poirel-Morales N., Gerard D., Kuhry J.G. A comparison of the fluorescence properties of TMA-DPH as a probe for plasma membrane and for endocytic membrane. Biochim Biophys Acta. 1239:1995;58-66.
26. Kuhry J.G., Fonteneau P., Duportail G., Maechling C., Laustriat G. Tma-dph. a suitable fluorescence polarization probe for specific plasma membrane fluidity studies in intact cells Cell Biophys. 5:1983;129-140.
27. Van Blitterswijk W.J., Van Hoeven R.P., Van Der Meer B.W. Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements. Biochim Biophys Acta. 644:1981;323-332.
28. Pottel H., Van Der Meer W., Herreman W. Correlation between the order parameters and the steady state fluorescence anisotropy of 1,6-diphenyl-1,3,5-hexatriene and an evaluation of membrane fluidity. Biochim Biophys Acta. 730:1983;181-186.
29. Kantar A., Giorgi P.L., Curatola G., Fiorini R. Alterations in membrane fluidity of diabetic polymorphonuclear leukocytes. Biochem Med Metabol Biol. 46:1991;422-426.
30. Zannoni C., Arcioni A., Cavatorta P. Fluorescence depolarization in liquid crystals and membrane bilayers. Chem Phys Lipids. 32:1983;179-250.
31. Fiorini R., Valentino M., Glaser M., Gratton E., Curatola G. Fluorescence lifetime distributions of 1,6-diphenyl-1,3,5-hexatriene reveal the effect of cholesterol on the microheterogeneity of erythrocyte membrane. Biochim Biophys Acta. 939:1988;485-492.
32. Parasassi T., Conti F., Glaser M., Gratton E. Detection of phospholipid phase separation. A multifrequency phase fluorimetry study of 1,6-diphenyl-1,3,5-hexatriene fluorescence J Biol Chem. 259:1984;14011-14017.
33. Klausner R.D., Kleinfeld A.M., Hoover R.L., Karnovsky M.J. Lipid domains in membranes. Evidence from structural perturbations induced by free fatty acids and lifetime, heterogeneity analysis J Biol Chem. 255:1980;1286-1295.
34. Weber G., Farris F.J. Synthesis and spectral properties of a hydrophobic fluorescent probe. 6-propionyl-2-(dimethylamino)naphthalene Biochemistry. 18:1979;3075-3078.
35. Chong P.L.G. Interaction of prodan and laurdan with membranes at high pressure. High Pressure Res. 5:1990;761-763.
36. Parasassi T., Gratton E. Membrane lipid domains and dynamics as detected by laurdan fluorescence. J Fluorescence. 5:1995;59-69.
37. Parasassi T., Di Stefano M., Loiero M., Ravagnan G., Gratton E. Influence of cholesterol on phospholipid bilayers phase domains as detected by laurdan fluorescence. Biophys J. 66:1994;120-132.
38. Parasassi T., De Stasio G., Ravagnan G., Rusch R.M., Gratton E. Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of laurdan fluorescence. Biophys J. 60:1991;179-180.
39. Lyons T.J., Jenkins A.J. Glycation, oxidation, and lipoxidation in the development of the complications of diabetes. A carbonyl stress hypothesis Diabetes Rev. 5:1997;365-391.
40. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications. A new perspective on an old paradigm Diabetes. 48:1999;1-9.
41. Masuda M., Murakami T., Egawa H., Murata K. Decreased fluidity of polymorphonuclear leukocyte membrane in streptozocin-induced diabetic rats. Diabetes. 39:1990;466-470.
42. Esmann V. The diabetic leukocyte. Enzyme. 13:1972;32-55.
43. Tsavaris N.B., Pangalis G.A., Variami E., Karabelis A., Kosmidis P., Raptis S. Association of neutrophil alkaline phosphatase activity and glycosylated haemoglobin in diabetes mellitus. Acta Haematol. 83:1990;22-25.
44. Bryszewska M., Epand R.M. Effects of sugar alcohols and disaccharides in inducing the hexagonal phase and altering membrane properties. Implications for diabetes mellitus Biochim Biophys Acta. 943:1988;485-492.
45. Wilson R.M., Reeves W.G. Neutrophil phagocytosis and killing in insulin-dependent diabetes. Clin Exp Immunol. 63:1986;478-484.
46. Labrouche S., Freyburger G., Gin H., Boisseau M.R., Cassagne C. Changes in phopholipid composition of blood cell membranes (erythrocyte, platelet, and polymorphonuclear) in different types of diabetes. clinical and biological correlations Metabolism. 45:1996;57-71.
47. Epand R.M. Lipid polymorphism and protein-lipid interactions. Biochim Biophys Acta. 1376:1998;353-368.
48. Badenhoop K., Walfish P.G., Rau H., Fischer S., Nicolay A., Bogner U., Schleusener H., Usadel K.H. Susceptibility and resistance alleles of human leukocyte antigene (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metabol. 80:1995;2112-2117.
49. Molenaar D.M., Palumbo P.J., Wilson W.R., Ritts R.E. Leukocyte chemotaxis in diabetic patients and their non-diabetic first degree relatives. Diabetes. 25:1976;880-883.